stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / MTD vs ROIV

MTD vs ROIV

Mettler-Toledo International Inc. and Roivant Sciences Ltd. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

MTD is the larger company ($22.8B vs $20.5B). On the fundamentals, MTD grows revenue faster (5.5% vs -19.1%); MTD earns a higher net margin (21.6% vs -3629.2%); ROIV has the stronger return on equity (-6.6% vs -3677.4%). Full numbers below — the stronger figure on each row is in green.
 Mettler-Toledo International Inc. (MTD)Roivant Sciences Ltd. (ROIV)
Market cap$22.8B$20.5B
Revenue (latest FY)$4.03B$8.26M
Net income (latest FY)$869.19M$-299.77M
Revenue growth (5y CAGR)5.5%-19.1%
Net margin21.6%-3629.2%
Return on equity-3677.4%-6.6%
P/E ratio26.5
Dividend yield
Profitable years (of last 10)101
Positive free cash flowYesNo
Compare with another company:

See the full MTD vs ROIV breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open MTD's full financials →   Open ROIV's full financials →

More comparisons

Frequently asked questions

Which is bigger, MTD or ROIV?

Mettler-Toledo International Inc. is larger by market capitalization — $22.8B versus $20.5B.

Which grows faster, MTD or ROIV?

Over the last five fiscal years, Mettler-Toledo International Inc. grew revenue faster — 5.5%/yr versus -19.1%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

MTD fundamentals → · ROIV fundamentals → · All 1,500+ companies → · Free screener →